Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next month. A price war now looms as Danish firm Novo Nordisk said it is

THE price of Mounjaro is set to soar, The Sun revealed yesterday – leaving slimmers desperate and worried at how they will afford the ‘life-changing’ drug. With the price hike

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition known as metabolic dysfunction-associated steatohepatitis.

The US government has been pressing pharmaceutical companies to reduce domestic drug prices, which has led some firms to raise prices in markets abroad. Eli Lilly stated the Mounjaro price hike is intended to 'align' the UK price with other European markets.

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets diabetes and obesity, competing with Wegovy

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro which launched in the country eight months ago.